"...800mg instead of 1200mg is GREAT news..."
It's already known that 800mg works well in clinical trials. It is now safe to assume that the 1200mg dosing is not as effective or safe.
In my opinion 'great news' would be that the new dosing works even better than the old. Then avx would be sitting on an even better therapy than at present.
All we have now is a status quo.... except of course that the fda won't be pestering Avexa to run loads of extra trials with the higher dose.
best wishes to holders
- Forums
- ASX - By Stock
- AVX
- breakout
breakout, page-24
-
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online